LABORATORIOS FARMACEUTICOS ROVI, S.A. «12345» Page 3 out of 5 10/05/2023 07:37 LABORATORIOS FARMACEUTICOS ROVI, S.A. On P&L The Company releases the press release related to the first quarter 2023 financial results Register number: 1858 25/04/2023 08:24 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company informs about the commencement of the clinical development of a new three-monthly formulation of Letrozole Register number: 1835 21/02/2023 08:14 LABORATORIOS FARMACEUTICOS ROVI, S.A. On corporate governance The Company informs about the agreements adopted by the Board of Directors. Register number: 1767 21/02/2023 08:08 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The company releases the presentation related to the 2022 full year financial results Register number: 1766 21/02/2023 08:06 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The company releases the press release related to the 2022 full year financial results Register number: 1765 21/02/2023 08:02 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The company releases the Integrated Report for the year 2022 Register number: 1764 23/11/2022 07:10 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company releases the presentation related to its strategy update because of its 2022 Capital Markets Day Register number: 1671 04/11/2022 07:36 LABORATORIOS FARMACEUTICOS ROVI, S.A. On P&L The Company releases the presentation related to the first nine months 2022 financial results Register number: 1646 04/11/2022 07:33 LABORATORIOS FARMACEUTICOS ROVI, S.A. On P&L The Company releases the press release related to the first nine month 2022 financial results Register number: 1645 11/04/2022 17:49 LABORATORIOS FARMACEUTICOS ROVI, S.A. On significant placements in financial instruments SALES OF SHARES OF LABORATORIOS FARMACÉUTICOS ROVI, S.A. Register number: 1395 Page 3 out of 5 «12345»
